The TcrB Gene is Part of the TcrYAZB Operon Conferring Copper Resistance in Enterococcus Faecium and Enterococcus Faecalis
Overview
Authors
Affiliations
The plasmid-localized tcrB (transferable copper-resistance gene B) gene from Enterococcus faecium was identified to be part of an operon called the tcrYAZB operon, which has a genetic organization similar to the copYZAB copper-homeostasis gene cluster from Enterococcus hirae. Putative promoter (P(tcr))- and repressor-binding sites highly similar to the E. hirae cop-promoter region were identified upstream of the tcrYAZB genes. The P(tcr) promoter was cloned in both the absence and the presence of the proximal repressor-encoding tcrY gene into a promoter-probe vector. Induction of the promoter was shown in liquid growth medium containing increasing concentrations of copper sulphate. To determine the growth advantage conferred by the tcrYAZB genes in a copper environment, a tcr-deletion mutant was isolated, and its growth was compared with that of its copper-resistant ancestor (strain A17sv1) in sublethal concentrations of copper sulphate. A competition assay using these two isogenic strains showed that copper sulphate concentrations of 3 mmol l(-1) and above are sufficient to select for copper resistance.
Lumen and mucosa-associated from the intestinal tract of organ donors.
Marsh A, Yaya A, Ng S, Chandrashekhar K, Roach J, Magness S Gut Microbiome (Camb). 2024; 1:e4.
PMID: 39296723 PMC: 11406413. DOI: 10.1017/gmb.2020.4.
Rebelo A, Almeida A, Peixe L, Antunes P, Novais C Antibiotics (Basel). 2023; 12(9).
PMID: 37760770 PMC: 10525130. DOI: 10.3390/antibiotics12091474.
Yazdankhah S, Skjerve E, Wasteson Y Microb Ecol Health Dis. 2020; 29(1):1548248.
PMID: 32547355 PMC: 7273308. DOI: 10.1080/16512235.2018.1548248.
Plasmids Shaped the Recent Emergence of the Major Nosocomial Pathogen Enterococcus faecium.
Arredondo-Alonso S, Top J, McNally A, Puranen S, Pesonen M, Pensar J mBio. 2020; 11(1).
PMID: 32047136 PMC: 7018651. DOI: 10.1128/mBio.03284-19.
Molecular Phenotyping and Genomic Characterization of a Novel Neuroactive Bacterium Strain, HU-1.
Lebovitz Y, Theus M Front Pharmacol. 2019; 10:1162.
PMID: 31636567 PMC: 6787272. DOI: 10.3389/fphar.2019.01162.